MedicaMetrix is a pioneering brand that is dedicated to revolutionizing the management of prostate disease. With a clear vision and mission, they aim to significantly advance men's healthcare by introducing innovative medical devices and assays that address this pressing health issue. Prostate disease is currently the second leading cause of male cancer death, and MedicaMetrix recognizes the urgent need to monitor its progression without resorting to radical intervention.

Their mission is to solve this global unmet need, benefiting both patients and physicians. By achieving this breakthrough in worldwide healthcare, MedicaMetrix not only provides immense value to patients and their families but also significantly lowers the societal cost of this disease. Founded in May 2020 and headquartered in Lowell, MA, USA, MedicaMetrix has already raised $5 million.

The brand collaborates closely with world-class medical research institutions and boasts renowned industry advisors who guide the development and commercialization of their innovative products